Hui-Hua Hsiao

745 total citations
17 papers, 555 citations indexed

About

Hui-Hua Hsiao is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Hui-Hua Hsiao has authored 17 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in Hui-Hua Hsiao's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (2 papers). Hui-Hua Hsiao is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and CAR-T cell therapy research (2 papers). Hui-Hua Hsiao collaborates with scholars based in Taiwan, United States and Australia. Hui-Hua Hsiao's co-authors include William J. Murphy, Ming-Chung Wang, Arta M. Monjazeb, Sheng-Fung Lin, Gail D. Sckisel, Chiun Hsu, Chi-Cheng Li, Ming-Chih Chang, Tsang-Wu Liu and Pei‐Jer Chen and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Hui-Hua Hsiao

14 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui-Hua Hsiao Taiwan 10 256 216 140 136 83 17 555
Nam Ik Han South Korea 13 285 1.1× 318 1.5× 92 0.7× 133 1.0× 87 1.0× 40 612
Alessandra Vaccaro Italy 11 350 1.4× 356 1.6× 153 1.1× 175 1.3× 86 1.0× 22 675
Yuka Igarashi Japan 13 83 0.3× 117 0.5× 256 1.8× 169 1.2× 161 1.9× 30 551
Patricia M. Niemietz Germany 6 253 1.0× 250 1.2× 283 2.0× 100 0.7× 77 0.9× 9 601
Yasuyuki Tomiyama Japan 12 243 0.9× 235 1.1× 39 0.3× 155 1.1× 113 1.4× 32 546
Amleto Fiocchi Italy 7 249 1.0× 241 1.1× 220 1.6× 158 1.2× 83 1.0× 7 630
Marta Mainetti Italy 3 235 0.9× 219 1.0× 217 1.6× 128 0.9× 61 0.7× 3 576
Johan J. van der Reijden Netherlands 10 84 0.3× 69 0.3× 91 0.7× 66 0.5× 104 1.3× 13 368
Roberto Aiolfi United States 7 281 1.1× 264 1.2× 252 1.8× 156 1.1× 80 1.0× 16 698
Mei Liu China 12 89 0.3× 96 0.4× 103 0.7× 69 0.5× 116 1.4× 31 387

Countries citing papers authored by Hui-Hua Hsiao

Since Specialization
Citations

This map shows the geographic impact of Hui-Hua Hsiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Hua Hsiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Hua Hsiao more than expected).

Fields of papers citing papers by Hui-Hua Hsiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Hua Hsiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Hua Hsiao. The network helps show where Hui-Hua Hsiao may publish in the future.

Co-authorship network of co-authors of Hui-Hua Hsiao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Hua Hsiao. A scholar is included among the top collaborators of Hui-Hua Hsiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Hua Hsiao. Hui-Hua Hsiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chang, Hsun‐Shuo, Ho‐Cheng Wu, Hui‐Chi Huang, et al.. (2024). The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations. Frontiers in Pharmacology. 15. 1403424–1403424.
2.
Tan, Peter, Ross Baker, Sung‐Eun Lee, et al.. (2024). Multicenter, Open-Label Phase 1/2a Study of Pxs-5505 and Ruxolitinib in Patients with Primary, Post-Polycythemia Vera (PV) or Post-Essential Thrombocythemia (ET) Myelofibrosis. Blood. 144(Supplement 1). 1001–1001. 1 indexed citations
3.
Hsiao, Hui-Hua, et al.. (2021). Unusual Bilateral Adrenal Tumors. Journal of Cancer Research and Practice. 8(1). 36–38.
4.
Wang, Hui-Ching, et al.. (2020). Gemcitabine/cisplatin/pembrolizumab-induced posterior reversible encephalopathy syndrome. Journal of Cancer Research and Practice. 7(3). 127–127.
5.
Chiang, Nai‐Jung, Kelvin K. Tsai, Chin‐Fu Hsiao, et al.. (2019). A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study. European Journal of Cancer. 124. 123–130. 13 indexed citations
6.
Hsu, Ya‐Ting, Hui‐Jen Tsai, Jeffrey S. Chang, et al.. (2018). Stem cell transplantation for T-cell lymphomas in Taiwan. Bone Marrow Transplantation. 53(8). 993–1000. 3 indexed citations
8.
Tsai, Hui‐Jen, Shih Sheng Jiang, Wen-Chun Hung, et al.. (2017). A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients. Scientific Reports. 7(1). 11253–11253. 61 indexed citations
9.
Pai, Chien-Chun Steven, Hui-Hua Hsiao, Kai Sun, et al.. (2014). Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels. Biology of Blood and Marrow Transplantation. 20(12). 1899–1904. 17 indexed citations
10.
Monjazeb, Arta M., Julia K. Tietze, Steven K. Grossenbacher, et al.. (2014). Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help. PLoS ONE. 9(8). e102709–e102709. 24 indexed citations
11.
Davari, Parastoo, Hui-Hua Hsiao, & Nasim Fazel. (2014). Mucosal Lichen Planus: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology. 15(3). 181–195. 26 indexed citations
12.
Hsiao, Hui-Hua, Yung Ching Liu, Hung‐Chen Wang, et al.. (2014). Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant. Transplant Infectious Disease. 16(6). 1003–1006. 6 indexed citations
13.
Bouchlaka, Myriam N., Gail D. Sckisel, Mingyi Chen, et al.. (2013). Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. The Journal of Experimental Medicine. 210(11). 2223–2237. 117 indexed citations
14.
Monjazeb, Arta M., Hui-Hua Hsiao, Gail D. Sckisel, & William J. Murphy. (2012). The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. Journal of Immunotoxicology. 9(3). 248–258. 27 indexed citations
15.
Sun, Kai, Hui-Hua Hsiao, Minghui Li, et al.. (2012). IFN-γ Receptor-Deficient Donor T Cells Mediate Protection from Graft-versus-Host Disease and Preserve Graft-versus-Tumor Responses after Allogeneic Bone Marrow Transplantation. The Journal of Immunology. 189(4). 2033–2042. 13 indexed citations
16.
Tietze, Julia K., Gail D. Sckisel, Hui-Hua Hsiao, & William J. Murphy. (2011). Antigen-specific versus Antigen-nonspecific Immunotherapeutic Approaches for Human Melanoma: The Need for Integration for Optimal Efficacy?. International Reviews of Immunology. 30(5-6). 238–293. 3 indexed citations
17.
Hsu, Chiun, Chao A. Hsiung, Ih‐Jen Su, et al.. (2008). A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial. Hepatology. 47(3). 844–853. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026